Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
0 competitors in HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
View Full LandscapeTarget Indication
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Clinical Trial
NCT06123494Last updated: 1/22/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
KNEE OSTEOARTHRITIS
Advanced Solid Tumor
Carcinoma, Hepatocellular
PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy